Yutide Therapeutics is an animal health biotechnology company that develops therapeutics and antimicrobial peptides for companion animals.
Yutide Therapeutics has raised $375K in total funding. The most recent round was Seed. The last funding was announced in June 2026.
Yutide Therapeutics is headquartered in Arlington, United States.
Yutide Therapeutics is an animal health biotechnology company that develops therapeutics and antimicrobial peptides for companion animals.
Yutide Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Yutide Therapeutics — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/yutide-therapeutics. Accessed August 13, 2026.
VCBacked. (2026). Yutide Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/yutide-therapeutics
{{cite web |title=Yutide Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/yutide-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated